Efficacy of Stem Cell Transplantation Compared to Rehabilitation Treatment of Patients With Cerebral Paralysis
CP
1 other identifier
interventional
300
1 country
1
Brief Summary
Cerebral palsy (CP) is described as a group of permanent disorders affecting motor development and posture, resulting in activity limitation attributed to nonprogressive disturbances of the fetal or infant brain. The prevalence of cerebral palsy has increased among the children with low birth-weight, jaundice, respiratory distress and intrauterine infection and so on. The incidence of cerebral palsy is increasing gradually with increased neonatal survival rate. Although there are many kinds of functional therapy programs especially the rehabilitation treatment for cerebral palsy, their effects are limited. Increasing cerebral palsy patients become a heavy burden to the family and society. Stem cell based therapy, a new prospective therapy for central nervous system disorders, has the potential to repair the damaged brain tissue in patients with cerebral palsy. In this study, 300 patients with cerebral palsy will be divided into three groups and the investigators will use mesenchymal stem cells derived from umbilical cord to treat 100 CP patients of them randomly. We will also follow up the other 100 patients who only receive rehabilitation treatment and another 100 patients who accept neither stem cell therapy nor rehabilitation treatment. On this basis, as the investigators we can compare the efficacy of cell therapy and rehabilitation treatments for cerebral palsy patients. Multiple sources of assessment were used to ascertain and classify all cases of cerebral palsy. Particularly the Gross Motor Function Measure (GMFM) as an important valid and reliable outcome measure, has made it possible to evaluate the severity of movement disability,change over time and the effects of clinical interventions. It also will be the primary outcome measure in follow-up analysis of this study.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_3
Started Oct 2013
Typical duration for phase_3
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 20, 2013
CompletedFirst Posted
Study publicly available on registry
August 28, 2013
CompletedStudy Start
First participant enrolled
October 1, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2016
CompletedDecember 27, 2017
July 1, 2015
2.2 years
August 20, 2013
December 23, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Gross Motor Function Measure Score
Gross Motor Function Measure-88 and Gross Motor Function Measure-66
Change from baseline at 12 monthes after enrollment or transplantation
Secondary Outcomes (1)
Routine Blood Test and Biochemical Test
Change from baseline at 12 monthes after enrollment or transplantation
Other Outcomes (1)
Magnetic resonance imaging (MRI)
Change from baseline at 12 monthes after enrollment or transplantation
Study Arms (3)
rehabilitation
ACTIVE COMPARATORPatients in the group accept rehabilitation for three weeks in hospital and other eleven months in their home under the guidance of physical therapist.
control
NO INTERVENTIONPatients receive no professional treatment in hospital or rehabilitation centre.
stem cell injection
EXPERIMENTALPatients in the group accept cell therapy including four times stem cells transplant via intrathecal injection.
Interventions
Patients only receive rehabilitation of physical therapy and occupational therapy.
Mesenchymal stem cells derived from umbilical cord are transplanted directly into subarachnoid by Lumbar puncture.
Eligibility Criteria
You may qualify if:
- Patients with diagnosis of cerebral palsy.
- Patients' curator must be able to give voluntary consent.
You may not qualify if:
- Intracranial infection.
- Severe respiratory and circulatory system diseases.
- Hematologic malignancies.
- Positive serological tests such as AIDS, hepatitis B virus, hepatitis C virus and syphilis (antigen or antibody).
- Tumors.
- Genetic and metabolic diseases.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
General Hospital of Chinese People's Armed Police Forces
Beijing, Beijing Municipality, 100050, China
Related Publications (6)
Pharoah PO, Platt MJ, Cooke T. The changing epidemiology of cerebral palsy. Arch Dis Child Fetal Neonatal Ed. 1996 Nov;75(3):F169-73. doi: 10.1136/fn.75.3.f169.
PMID: 8976681BACKGROUNDRichards CL, Malouin F. Cerebral palsy: definition, assessment and rehabilitation. Handb Clin Neurol. 2013;111:183-95. doi: 10.1016/B978-0-444-52891-9.00018-X.
PMID: 23622163BACKGROUNDHimmelmann K. Epidemiology of cerebral palsy. Handb Clin Neurol. 2013;111:163-7. doi: 10.1016/B978-0-444-52891-9.00015-4. No abstract available.
PMID: 23622160BACKGROUNDReddihough DS, Collins KJ. The epidemiology and causes of cerebral palsy. Aust J Physiother. 2003;49(1):7-12. doi: 10.1016/s0004-9514(14)60183-5.
PMID: 12600249BACKGROUNDRethlefsen SA, Ryan DD, Kay RM. Classification systems in cerebral palsy. Orthop Clin North Am. 2010 Oct;41(4):457-67. doi: 10.1016/j.ocl.2010.06.005.
PMID: 20868878BACKGROUNDLubis MU, Tjipta GD, Marbun MD, Saing B. Cerebral palsy. Paediatr Indones. 1990 Mar-Apr;30(3-4):65-70.
PMID: 2075008BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Yihua An, Doctor
the General Hospital of Chinese People's Armed Police Forces
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 20, 2013
First Posted
August 28, 2013
Study Start
October 1, 2013
Primary Completion
December 1, 2015
Study Completion
December 1, 2016
Last Updated
December 27, 2017
Record last verified: 2015-07